Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study
Titel:
Long-term effectiveness of natalizumab on MRI outcomes and no evidence of disease activity in relapsing-remitting multiple sclerosis patients treated in a Czech Republic real-world setting: A longitudinal, retrospective study
Auteur:
Horakova, Dana Uher, Tomas Krasensky, Jan Seidl, Zdeněk Ribbens, Annemie Van Hecke, Wim Billiet, Thibo Koendgen, Harold Freudensprung, Ulrich Hyde, Robert Vaneckova, Manuela